Skip to main content
Erschienen in: Endocrine 2/2019

15.04.2019 | Original Article

Network-based transcriptomic analysis reveals novel melatonin-sensitive genes in cardiovascular system

verfasst von: Ke Li, Fan Hu, Wan Xiong, Qing Wei, Fang-Fang Liu

Erschienen in: Endocrine | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Heart disease is a major cause of mortality and disability worldwide. Melatonin is a neuroendocrine hormone and has been found to be protective in heart disease. However, the molecular basis underlying this cardioprotective effect is not fully understood. Here we aim to investigate melatonin-sensitive genes in cardiovascular system using public gene expression databases.

Methods

An innovative genomic analysis method, the weighted gene co-expression network analysis (WGCNA) combined with differential gene expression analysis, was used in this study. The algorithm was implemented in R/Bioconductor.

Results

Using this method, we provide a comprehensive characterization of transcriptional profiles associated with melatonin treatment. We found that 357 differentially expressed genes (DEGs) were highly sensitive to melatonin in mouse myocardium. Enrichment analysis showed that these 357 genes were mostly related to GO:0051984 (positive regulation of chromosome segregation), GO:0016605 (PML body) and GO:0006281 (DNA repair). We further obtained 5 hub genes from the 357 DEGs, including Set, Dhx40, Scaf11, Cfh, and Nup43.

Conclusions

We identified numerous melatonin-sensitive genes and further identified five hub genes. The five novel genes are possibly associated with the myocardial benefits of melatonin.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat G.T. Haskell, B.C. Jensen, L.A. Samsa, D. Marchuk, W. Huang, C. Skrzynia, C. Tilley, B.A. Seifert, E.A. Rivera-Munoz, B. Koller, K.C. Wilhelmsen, J. Liu, H. Alhosaini, K.E. Weck, J.P. Evans, J.S. Berg, Whole exome sequencing identifies truncating variants in nuclear envelope genes in patients with cardiovascular disease. Circ. Cardiovasc. Genet. 10(3) (2017). https://doi.org/10.1161/CIRCGENETICS.116.001443 G.T. Haskell, B.C. Jensen, L.A. Samsa, D. Marchuk, W. Huang, C. Skrzynia, C. Tilley, B.A. Seifert, E.A. Rivera-Munoz, B. Koller, K.C. Wilhelmsen, J. Liu, H. Alhosaini, K.E. Weck, J.P. Evans, J.S. Berg, Whole exome sequencing identifies truncating variants in nuclear envelope genes in patients with cardiovascular disease. Circ. Cardiovasc. Genet. 10(3) (2017). https://​doi.​org/​10.​1161/​CIRCGENETICS.​116.​001443
9.
Zurück zum Zitat M. Li, A. Makkinje, Z. Damuni, The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J. Biol. Chem. 271(19), 11059–62 (1996)CrossRefPubMed M. Li, A. Makkinje, Z. Damuni, The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J. Biol. Chem. 271(19), 11059–62 (1996)CrossRefPubMed
14.
Zurück zum Zitat T.B. Lin, M.C. Hsieh, C.Y. Lai, J.K. Cheng, H.H. Wang, Y.P. Chau, G.D. Chen, H.Y. Peng, Melatonin relieves neuropathic allodynia through spinal MT2-enhanced PP2Ac and downstream HDAC4 shuttling-dependent epigenetic modification of hmgb1 transcription. J. Pineal Res. 60(3), 263–76 (2016). https://doi.org/10.1111/jpi.12307 CrossRefPubMed T.B. Lin, M.C. Hsieh, C.Y. Lai, J.K. Cheng, H.H. Wang, Y.P. Chau, G.D. Chen, H.Y. Peng, Melatonin relieves neuropathic allodynia through spinal MT2-enhanced PP2Ac and downstream HDAC4 shuttling-dependent epigenetic modification of hmgb1 transcription. J. Pineal Res. 60(3), 263–76 (2016). https://​doi.​org/​10.​1111/​jpi.​12307 CrossRefPubMed
15.
Zurück zum Zitat K.C. Koeijvoets, S.P. Mooijaart, G.M. Dallinga-Thie, J.C. Defesche, E.W. Steyerberg, R.G. Westendorp, J.J. Kastelein, P.M. van Hagen, E.J. Sijbrands, Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia. Eur. Heart J. 30(5), 618–23 (2009). https://doi.org/10.1093/eurheartj/ehn568 CrossRefPubMed K.C. Koeijvoets, S.P. Mooijaart, G.M. Dallinga-Thie, J.C. Defesche, E.W. Steyerberg, R.G. Westendorp, J.J. Kastelein, P.M. van Hagen, E.J. Sijbrands, Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia. Eur. Heart J. 30(5), 618–23 (2009). https://​doi.​org/​10.​1093/​eurheartj/​ehn568 CrossRefPubMed
Metadaten
Titel
Network-based transcriptomic analysis reveals novel melatonin-sensitive genes in cardiovascular system
verfasst von
Ke Li
Fan Hu
Wan Xiong
Qing Wei
Fang-Fang Liu
Publikationsdatum
15.04.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01925-w

Weitere Artikel der Ausgabe 2/2019

Endocrine 2/2019 Zur Ausgabe

Endocrine imaging

Pituitary crush

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.